Litigation Details for Acorda Therapeutics Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
✉ Email this page to a colleague
Acorda Therapeutics Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-07-17 |
| Court | District Court, D. Delaware | Date Terminated | 2017-04-25 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 8,007,826; 8,354,437; 8,440,703; 8,663,685 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Acorda Therapeutics Inc. v. Teva Pharmaceuticals USA Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Acorda Therapeutics Inc. v. Teva Pharmaceuticals USA Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-07-17 | 1 | Teva for patent infringement of United States Patent Nos. 5,540,938 (the “’938 patent”), 8,007,826 (the …the “’826 patent”), 8,354,437 (the “’437 patent”), 8,440,703 (the “’703 patent”) and 8,663,685 (the “’685… patent, ’703 patent, and ’685 patent, and the right to sue for infringement thereof. 7. …the ’938 patent. A copy of the ’938 patent is attached hereto as Exhibit A. The ’826 Patent 23… for the ’938 patent as July 30, 2018, the ’826 patent as May 26, 2027, the ’437 patent as December 22 | External link to document | |
| 2017-05-16 | 29 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,540,938; 8,007,826 B2; 8,354,437…2014 25 April 2017 1:14-cv-00941 830 Patent None District Court, D. Delaware | External link to document | |
| 2014-07-17 | 4 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,540,938; 8,007,826 B2; 8,354,437…2014 25 April 2017 1:14-cv-00941 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
